These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8911125)

  • 1. Modulation of [5-125I]iododeoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors.
    Mester J; DeGoeij K; Sluyser M
    Eur J Cancer; 1996 Aug; 32A(9):1603-8. PubMed ID: 8911125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331.
    Panadero A; Yin MB; Voigt W; Rustum YM
    Oncol Res; 1995; 7(2):73-81. PubMed ID: 7579730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.
    Jackman AL; Kelland LR; Kimbell R; Brown M; Gibson W; Aherne GW; Hardcastle A; Boyle FT
    Br J Cancer; 1995 May; 71(5):914-24. PubMed ID: 7537518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
    Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
    Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer.
    Jackman AL; Farrugia DC; Gibson W; Kimbell R; Harrap KR; Stephens TC; Azab M; Boyle FT
    Eur J Cancer; 1995; 31A(7-8):1277-82. PubMed ID: 7577036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of 5-fluorouracil cytotoxicity through thymidylate synthase and NF-kappaB down-regulation and its application on the radiolabelled iododeoxyuridine therapy on human hepatoma cell.
    Wang HE; Wu HC; Kao SJ; Tseng FW; Wang YS; Yu HM; Chou SL; Yen SH; Chi KH
    Biochem Pharmacol; 2005 Feb; 69(4):617-26. PubMed ID: 15670580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs in therapy of colorectal cancer: preclinical studies.
    Rustum YM; Cao S
    Semin Oncol; 1999 Dec; 26(6):612-20. PubMed ID: 10606254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
    Bagshawe KD; Sharma K; Southall PJ; Boden JA; Boxer GM; Patridge TA; Antoniw P; Pedley RB
    Br J Radiol; 1991 Jan; 64(757):37-44. PubMed ID: 1998836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
    Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
    Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.
    Rustum YM; Harstrick A; Cao S; Vanhoefer U; Yin MB; Wilke H; Seeber S
    J Clin Oncol; 1997 Jan; 15(1):389-400. PubMed ID: 8996166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma.
    Meropol NJ; Niedzwiecki D; Hollis D; Schilsky RL; Mayer RJ;
    Cancer; 2001 Apr; 91(7):1256-63. PubMed ID: 11283924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil.
    Naguib FN; Hao SN; el Kouni MH
    Cancer Res; 1994 Oct; 54(19):5166-70. PubMed ID: 7923135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
    Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
    Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action.
    Saleem A; Yap J; Osman S; Brady F; Suttle B; Lucas SV; Jones T; Price PM; Aboagye EO
    Lancet; 2000 Jun; 355(9221):2125-31. PubMed ID: 10902627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.
    Chi KH; Wang HE; Wang YS; Chou SL; Yu HM; Tseng YH; Hwang IM; Lui WY
    J Nucl Med; 2004 Mar; 45(3):478-84. PubMed ID: 15001691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
    Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Radiat Environ Biophys; 1985; 24(3):219-26. PubMed ID: 4034927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and WAF1 are induced and Rb protein is hypophosphorylated during cell growth inhibition by the thymidylate synthase inhibitor ZD1694 (Tomudex).
    Yin MB; Voigt W; Panadero A; Vanhoefer U; Frank C; Pajovic S; Azizkhan J; Rustum YM
    Mol Pharmacol; 1997 Apr; 51(4):630-6. PubMed ID: 9106628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.